Doctors Blame Institutions, Lack of Training, Lack of Knowledge for Failure to Treat Substance Use Disorders
A shocking new systematic review funded by the National Institutes of Health found that many doctors claim ignorance of how to treat substance use disorders.
Public Policy and America’s Opioid Epidemic
Two leading neuroscience researchers from Mount Sinai lay out their public policy recommendations for managing the opioid epidemic.
Do Telehealth Interventions for Substance Use Disorders Lead to Superior Results?
The COVID-19 pandemic sparked a new era in telehealth interventions for substance use disorders. New studies show it’s working out pretty well.
Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
A New Book Makes The Case That Addiction Is Not a Brain Disease
A new book and a new brain study are raising doubts about addiction as a chronic brain condition.
Advances in Epigenetic Editing for Addiction Treatment
Crispr and other technologies are allowing researchers to turn on and off genetic and cellular switches impacting addictive behavior.